Publications
Recent + Selected
Recent Selected Publications
Cancer Population Sciences
Singh Ospina N, Iniguez-Ariza NM, Castro MR. Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment. BMJ. 2020 PMID:31911452
Cicali EJ, Smith DM, Duong BQ, Kovar LG, Cavallari LH, Johnson JA. A Scoping Review of the Evidence Behind CYP2D6 Inhibitor Classifications. Clin Pharmacol Ther. 2020 PMID:31910286
Wijayabahu AT, Egan KM, Yaghjyan L. Uterine cancer in breast cancer survivors: a systematic review. Breast Cancer Res Treat. 2020 PMID:31897901
Herremans KM, Riner AN, Cameron ME, Trevino JG. The Microbiota and Cancer Cachexia. Int J Mol Sci. 2019 PMID:31842339 | PMCID:PMC6940781
Perbtani Y, Forsmark CE. Update on the diagnosis and management of exocrine pancreatic insufficiency. F1000Res. 2019 PMID:31824646 | PMCID:PMC6880257
Hsiao CP, Dickinson K, Gonzalez-Mercado V, Kelly DL, Lukkahatai N, McCabe M, Mayo S, Musanti R, Saligan LN. Consortium Building for Nurse Scientists Interested in Symptoms Research in the Era of Precision Health. J Nurs Scholarsh. 2019 PMID:31804774
Beaty BT, Moon DH, Shen CJ, Amdur RJ, Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman TG, Thorp B, Blumberg JM, Patel SN, Weissler MC, Yarbrough WG, Nathan C S, Parker J, Hayes DN, Weck KE, Ramkissoon LA, Mendenhall WM, Dagan R, Tan X, et al. PIK3CA mutation in HPV-associated OPSCC patients receiving deintensified chemoradiation. J Natl Cancer Inst. 2019 PMID:31747025
Chebet JJ, Thomson CA, Kohler LN, Ehiri JE, Luo J, Cheng TD, Pan K, Chlebowski RT, Nassir R, Sealy-Jefferson S, Manson JE, Saquib N, Bell ML. Association of Diet Quality and Physical Activity on Obesity-Related Cancer Risk and Mortality in Black Women: Results from the Women’s Health Initiative. Cancer Epidemiol Biomarkers Prev. 2020 PMID:31915146
Dandoy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales MA, et al. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant. JAMA Netw Open. 2020 PMID:31913492
Affram KO, Smith T, Ofori E, Krishnan S, Underwood P, Trevino JG, Agyare E. Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells. J Drug Deliv Sci Technol. 2020 PMID:31903101 | PMCID:PMC6941746
Dyal BW, Powell-Roach KL, Robison J, Campbell B, Yoon SL, Wilkie DJ. Sublingual Versus Swallowed Morphine: A Comparison. Cancer Nurs. 2019 PMID:31895174
Cheng TD, Yao S, Omilian AR, Khoury T, Buas MF, Payne-Ondracek R, Sribenja S, Bshara W, Hong CC, Bandera EV, Davis W, Higgins MJ, Ambrosone CB. FOXA1 protein expression in ER+ and ER- breast cancer in relation to parity and breastfeeding in Black and White women. Cancer Epidemiol Biomarkers Prev. 2019 PMID:31871111
Fisher CL, Wright KB, Rising CJ, Mullis MD, Afanaseva D, Burke-Garcia A, Cai X. Culturally Appropriate Breast Cancer and Environmental Risk Messages: Targeting Racially and Ethnically Diverse Mothers. J Cancer Educ. 2019 PMID:31820415
Salloum RG, Huo J, Lee JH, Lee J, Dallery J, George T, Warren G. Tobacco and E-cigarette use among cancer survivors in the United States. PLoS One. 2019 PMID:31815948 | PMCID:PMC6901228
Ezeani A, Odedina F, Rivers D, Fatiregun O, Akinremi T. SWOT Analysis of Oncology Clinical Trials in Africa: A Town Hall Report From the Global Congress on Oncology Clinical Trials in Blacks. J Glob Oncol. 2019 PMID:31809225 | PMCID:PMC6939738
Diaby V, Alqhtani H, van Boemmel-Wegmann S, Wang CY, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G. A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan. Breast. 2019 PMID:31805500
Johnson Shen M, Elston Lafata J, D’Agostino TA, Bylund CL. Lower Adherence: A Description of Colorectal Cancer Screening Barrier Talk. J Health Commun. 2019 PMID:31795843
Yang GS, Mi X, Jackson-Cook CK, Starkweather AR, Lynch Kelly D, Archer KJ, Zou F, Lyon DE. Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year. Epigenetics. 2019 PMID:31793401
Rapp CT, Chera BS, Morris CG, Amdur RJ, Kirwan JM, Mendenhall WM. Radiation treatment of soft palate squamous cell carcinoma. Head Neck. 2019 PMID:31773865
de Pauli Paglioni M, Palmier NR, Prado-Ribeiro AC, Fregnani ER, Gaviao MBD, Brandao TB, Lopes MA, Ribeiro APD, Migliorati CA, Santos-Silva AR. The impact of radiation caries in the quality of life of head and neck cancer patients. Support Care Cancer. 2019 PMID:31773272
Callaway CS, Delitto AE, Patel R, Nosacka RL, D’Lugos AC, Delitto D, Deyhle MR, Trevino JG, Judge SM, Judge AR. IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy. Cancers (Basel). 2019 PMID:31769424
Xiao H, Jiang X, Chen C, Wang W, Wang CY, Ali AA, Berthe A, Moussa RK, Diaby V. Using time series analysis to forecast the health-related quality of life of post-menopausal women with non-metastatic ER+ breast cancer: A tutorial and case study. Res Social Adm Pharm. 2019 PMID:31753693
Bates JE, Flampouri S, Hoppe RT, Li Z, Mendenhall NP, Hoppe BS. Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors. Acta Oncol. 2019 PMID:31742489
Canzona MR, Fisher CL, Wright KB, Ledford CJW. Talking about sexual health during survivorship: understanding what shapes breast cancer survivors’ willingness to communicate with providers. J Cancer Surviv. 2019 PMID:31741248
Kharod SM, Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Morris CG, Bradfield S, Sandler ES, Bradley JA. Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base. Pediatr Blood Cancer. 2020 PMID:31736243
Kirsch JL, Robinson ME, McCrae CS, Kacel EL, Wong SS, Patidar S, Sannes TS, Garey S, Castagno JC, Pereira DB. Associations Among Sleep Latency, Subjective Pain, and Thermal Pain Sensitivity in Gynecologic Cancer. Pain Med. 2020 PMID:30481329
Cancer Therapeutics & Host Response
Holtzman AL, Mendenhall WM. High-dose conformal proton therapy for clinical perineural invasion in cutaneous head and neck cancer. Oral Oncol. 2019 PMID:31812007
Crispen PL, Kusmartsev S. Mechanisms of immune evasion in bladder cancer. Cancer Immunol Immunother. 2020 PMID:31811337
Hassan S, Sebastian S, Maharjan S, Lesha A, Carpenter AM, Liu X, Xie X, Livermore C, Zhang YS, Zarrinpar A. Liver-on-a-Chip Models of Fatty Liver Disease. Hepatology. 2020 PMID:31909504
Thomas RM, Jobin C. Microbiota in pancreatic health and disease: the next frontier in microbiome research. Nat Rev Gastroenterol Hepatol. 2020 PMID:31811279
Unni M, Zhang J, George TJ, Segal MS, Fan ZH, Rinaldi C. Engineering magnetic nanoparticles and their integration with microfluidics for cell isolation. J Colloid Interface Sci. 2019 PMID:31911225
Corral PA, Botello JF, Xing C. Design, synthesis, and enzymatic characterization of quinazoline-based CYP1A2 inhibitors. Bioorg Med Chem Lett. 2020 PMID:31784319
Yang Y, Zheng W, Cai Q, Shrubsole MJ, Pei Z, Brucker R, Steinwandel M, Bordenstein SR, Li Z, Blot WJ, Shu XO, Long J. Racial Differences in the Oral Microbiome: Data from Low-Income Populations of African Ancestry and European Ancestry. mSystems. 2019 PMID:31771977 | PMCID:PMC6880044
Beaty BT, Moon DH, Shen CJ, Amdur RJ, Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman TG, Thorp B, Blumberg JM, Patel SN, Weissler MC, Yarbrough WG, Nathan C S, Parker J, Hayes DN, Weck KE, Ramkissoon LA, Mendenhall WM, Dagan R, Tan X, et al. PIK3CA mutation in HPV-associated OPSCC patients receiving deintensified chemoradiation. J Natl Cancer Inst. 2019 PMID:31747025
Flores C, Wildes T, Dean BD, Moore G, Drake J, Abraham R, Gil J, Yegorov O, Yang C, Dean J, Moneypenny C, Shin D, Pham C, Krauser J, King J, Grant G, Driscoll T, Kurtzberg J, McLendon R, Gururangan S, Mitchell D. Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy. Sci Adv. 2019 PMID:31807694 | PMCID:PMC6881165
Chatzkel J, Mocha J, Smith J, Zhou JM, Kim Y, El-Haddad G, Zhang J. Circulating tumor cells and γH2AX as biomarkers for responsiveness to radium-223 in advanced prostate cancer patients. Future Sci OA. 2019 PMID:31915536 | PMCID:PMC6920735
Uckun FM, Cogle CR, Lin TL, Qazi S, Trieu VN, Schiller G, Watts JM. A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia. Cancers (Basel). 2019 PMID:31888052
Flores-Toro JA, Luo D, Gopinath A, Sarkisian MR, Campbell JJ, Charo IF, Singh R, Schall TJ, Datta M, Jain RK, Mitchell DA, Harrison JK. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas. Proc Natl Acad Sci U S A. 2019 PMID:31879345
Dziegielewski PT, McNeely ML, Ashworth N, O’Connell DA, Barber B, Courneya KS, Debenham BJ, Seikaly H. 2b or not 2b? Shoulder function after level 2b neck dissection: A double-blind randomized controlled clinical trial. Cancer. 2019 PMID:31873950
Freidlin B, Allegra CJ, Korn EL. Moving Molecular Profiling to Routine Clinical Practice: A Way Forward? J Natl Cancer Inst. 2019 PMID:31868907
Tu S, Zhou X, Guo Z, Huang R, Yue C, He Y, Li M, Chen Y, Liu Y, Chang LJ, Li Y. CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma. Front Oncol. 2019 PMID:31867275 | PMCID:PMC6904344
Vlasak AL, Shin DH, Kubilis PS, Roper SN, Karachi A, Hoh BL, Rahman M. Comparing standard performance and outcome measures in hospitalized pituitary tumor patients with secretory versus non-secretory tumors. World Neurosurg. 2019 PMID:31863896
Kates MM, Goldstein LE, Thomas RM. Fungating Anal Mass: Extrapulmonary Small Cell Carcinoma Masquerading as a Hemorrhoid. J Gastrointest Surg. 2019 PMID:31848872
Wang M, Law ME, Davis BJ, Yaaghubi E, Ghilardi AF, Ferreira RB, Chiang CW, Guryanova OA, Kopinke D, Heldermon CD, Castellano RK, Law BK. Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway. Cell Death Discov. 2019 PMID:31839995 | PMCID:PMC6904486
Oza AM, Matulonis UA, Alvarez Secord A, Nemunaitis J, Roman LD, Blagden SP, Banerjee S, McGuire WP, Ghamande S, Birrer MJ, Fleming GF, Markham MJ, Hirte HW, Provencher DM, Basu B, Kristeleit R, Armstrong DK, Schwartz B, Braly P, Hall GD, Nephew KP, Jueliger S, et al. A randomized phase 2 trial of epigenetic priming with guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer. Clin Cancer Res. 2019 PMID:31831561
Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M, Hwang EI, Gururangan S, Hansford JR, Fouladi M, Nobusawa S, Laquerriere A, Delisle MB, Fangusaro J, Forest F, Toledano H, Solano-Paez P, Leary S, Birks D, Hoffman LM, Szathmari A, Faure-Conter C, et al. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathol. 2019 PMID:31820118
Zhang X, Pham K, Li D, Schutte RJ, Gonzalo DH, Zhang P, Oshins R, Tan W, Brantly M, Liu C, Ostrov DA. A Novel Small Molecule Inhibits Intrahepatocellular Accumulation of Z-Variant Alpha 1-Antitrypsin In Vitro and In Vivo. Cells. 2019 PMID:31817705
Salloum RG, Huo J, Lee JH, Lee J, Dallery J, George T, Warren G. Tobacco and E-cigarette use among cancer survivors in the United States. PLoS One. 2019 PMID:31815948 | PMCID:PMC6901228
Penney KL, Banbury BL, Bien S, Harrison TA, Hua X, Phipps AI, Sun W, Song M, Joshi AD, Alberts SR, Allegra CJ, Atkins J, Colangelo LH, George TJ, Goldberg RM, Lucas PC, Nair SG, Shi Q, Sinicrope FA, Wolmark N, Yothers G, Peters U, et al. Genetic Variant Associated with Survival of Patients with Stage II-III Colon Cancer. Clin Gastroenterol Hepatol. 2019 PMID:31811950
Liu APY, Gudenas B, Lin T, Orr BA, Klimo P Jr, Kumar R, Bouffet E, Gururangan S, Crawford JR, Kellie SJ, Chintagumpala M, Fisher MJ, Bowers DC, Hassall T, Indelicato DJ, Onar-Thomas A, Ellison DW, Boop FA, Merchant TE, Robinson GW, Northcott PA, Gajjar A. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. 2019 PMID:31802236
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2019 PMID:31802125
Jacobs SA, Robidoux A, Abraham J, Pérez-Garcia JM, La Verde N, Orcutt JM, Cazzaniga ME, Piette F, AntolÃn S, Aguirre E, Cortes J, Llombart-Cussac A, Di Cosimo S, Kim RS, Feng H, Lipchik C, Lucas PC, Srinivasan A, Wang Y, Song N, Gavin PG, Balousek AD, Paik S, Allegra CJ, et al. NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2(+) breast cancer. Breast Cancer Res. 2019 PMID:31796073 | PMCID:PMC6892191
Khan S, Zhang X, Lv D, Zhang Q, He Y, Zhang P, Liu X, Thummuri D, Yuan Y, Wiegand JS, Pei J, Zhang W, Sharma A, McCurdy CR, Kuruvilla VM, Baran N, Ferrando AA, Kim YM, Rogojina A, Houghton PJ, Huang G, Hromas R, Konopleva M, Zheng G, Zhou D. A selective BCL-X(L) PROTAC degrader achieves safe and potent antitumor activity. Nat Med. 2019 PMID:31792461
Sato T, Tatekoshi A, Takada K, Iyama S, Kamihara Y, Jawaid P, Rehman MU, Noguchi K, Kondo T, Kajikawa S, Arita K, Wada A, Murakami J, Arai M, Yasuda I, Dang NH, Hatano R, Iwao N, Ohnuma K, Morimoto C. DPP8 is a novel therapeutic target for multiple myeloma. Sci Rep. 2019 PMID:31792328
Park WG, Li L, Appana S, Wei W, Stello K, Andersen DK, Hughes SJ, Whitcomb DC, Brand RE, Yadav D, Habtezion A; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and without diabetes. Pancreatology. 2019 PMID:31791885
Luo H, Zhu G, Xu J, Lai Q, Yan B, Guo Y, Fung TK, Zeisig BB, Cui Y, Zha J, Cogle C, Wang F, Xu B, Yang FC, Li W, So CWE, Qiu Y, Xu M, Huang S. HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in Mice. Cancer Cell. 2019 PMID:31786140 | PMCID:PMC6917035
Rapp CT, Chera BS, Morris CG, Amdur RJ, Kirwan JM, Mendenhall WM. Radiation treatment of soft palate squamous cell carcinoma. Head Neck. 2019 PMID:31773865
Larkin T, Macak R, Lagmay J, Horn B. Chordoma of the Clivus and Acute Myeloid Leukemia: Is There a Connection? J Pediatr Hematol Oncol. 2019 PMID:31764514
Ladd AD, Cho JJ, Hughes SJ. Relapsing Acute Pancreatitis Caused by a Mucinous Cystic Neoplasm. J Gastrointest Surg. 2019 PMID:31754988
Dastmalchi F, Karachi A, Yang C, Azari H, Sayour EJ, Dechkovskaia A, Vlasak AL, Saia ME, Lovaton RE, Mitchell DA, Rahman M. Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling. J Immunother Cancer. 2019 PMID:31753028 | PMCID:PMC6873439
Bates JE, Flampouri S, Hoppe RT, Li Z, Mendenhall NP, Hoppe BS. Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors. Acta Oncol. 2019 PMID:31742489
Manochakian R, George TJ, Wood M, Polansky M, Baer A, Grupe A, Shyr Y, Wang C, Horn L. Establishing and Evaluating an ASCO Learning Cohort: a Longitudinal Project Assessing the Learning Needs and Behaviors of Oncology Professionals. J Cancer Educ. 2019 PMID:31741200
Kharod SM, Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Morris CG, Bradfield S, Sandler ES, Bradley JA. Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base. Pediatr Blood Cancer. 2020 PMID:31736243
Gopinath A, Mubeen A, Baskovich B, Mohammed I, Makary R, Hoy ES, Dagan R, Smotherman C, Gautam S, Fernandes RP, Bunnell AM, Pirgousis P, Alkhasawneh A. Prognostic significance of venous invasion in node-negative head and neck squamous cell carcinoma. J Oral Pathol Med. 2019 PMID:31732985
Grippin AJ, Wummer B, Wildes T, Dyson K, Trivedi V, Yang C, Sebastian M, Mendez-Gomez HR, Padala S, Grubb M, Fillingim M, Monsalve A, Sayour EJ, Dobson J, Mitchell DA. Dendritic Cell-Activating Magnetic Nanoparticles Enable Early Prediction of Antitumor Response with Magnetic Resonance Imaging. ACS Nano. 2019 PMID:31730332
Long Y, Tao H, Karachi A, Grippin AJ, Jin L, Chang YE, Zhang W, Dyson KA, Hou AY, Na M, Deleyrolle LP, Sayour EJ, Rahman M, Mitchell DA, Lin Z, Huang J. Dysregulation of glutamate transport enhances Treg function that promotes VEGF blockade resistance in glioblastoma. Cancer Res. 2019 PMID:31723000
Mechanisms of Oncogenesis
Owens JL, Beketova E, Liu S, Tinsley SL, Asberry AM, Deng X, Huang J, Li C, Wan J, Hu CD. PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes. iScience. 2019 PMID:31884170 | PMCID:PMC6941881
Lele TP, Brock A, Peyton SR. Emerging Concepts and Tools in Cell Mechanomemory. Ann Biomed Eng. 2019 PMID:31745676
Liu Q, Borcherding NC, Shao P, Maina PK, Zhang W, Qi HH. Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance. EBioMedicine. 2020 PMID:31923801
Naik NG, Nguyen TH, Roberts L, Fischer LT, Glickman K, Golas G, Papp B, Toth Z. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV. PLoS Pathog. 2020 PMID:31923286
Burton EM, Goldbach-Mansky R, Bhaduri-McIntosh S. A promiscuous inflammasome sparks replication of a common tumor virus. Proc Natl Acad Sci U S A. 2020 PMID:31919284
Naipauer J, Rosario S, Gupta S, Premer C, Mendez-Solis O, Schlesinger M, Ponzinibbio V, Jain V, Gay L, Renne R, Chan HL, Morey L, Salyakina D, Abba M, Williams S, Hare JM, Goldschmidt-Clermont PJ, Mesri EA. PDGFRA defines the mesenchymal stem cell Kaposi’s sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment. PLoS Pathog. 2019 PMID:31881074
Xu H, Perez RD, Frey TR, Burton EM, Mannemuddhu S, Haley JD, McIntosh MT, Bhaduri-McIntosh S. Novel replisome-associated proteins at cellular replication forks in EBV-transformed B lymphocytes. PLoS Pathog. 2019 PMID:31841561 | PMCID:PMC6936862
Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, Adank MA, Adlard J, Aittomaki K, Andrulis IL, Ang P, Barwell J, Bernstein JL, Bobolis K, Borg Å, Blomqvist C, Claes KBM, Concannon P, et al. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. J Clin Oncol. 2019 PMID:31841383
Wang M, Law ME, Davis BJ, Yaaghubi E, Ghilardi AF, Ferreira RB, Chiang CW, Guryanova OA, Kopinke D, Heldermon CD, Castellano RK, Law BK. Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway. Cell Death Discov. 2019 PMID:31839995 | PMCID:PMC6904486
Hoffman BA, Wang Y, Feldman ER, Tibbetts SA. Epstein-Barr virus EBER1 and murine gammaherpesvirus TMER4 share conserved in vivo function to promote B cell egress and dissemination. Proc Natl Acad Sci U S A. 2019 PMID:31796588 | PMCID:PMC6926008
Khan S, Zhang X, Lv D, Zhang Q, He Y, Zhang P, Liu X, Thummuri D, Yuan Y, Wiegand JS, Pei J, Zhang W, Sharma A, McCurdy CR, Kuruvilla VM, Baran N, Ferrando AA, Kim YM, Rogojina A, Houghton PJ, Huang G, Hromas R, Konopleva M, Zheng G, Zhou D. A selective BCL-X(L) PROTAC degrader achieves safe and potent antitumor activity. Nat Med. 2019 PMID:31792461
Luo H, Zhu G, Xu J, Lai Q, Yan B, Guo Y, Fung TK, Zeisig BB, Cui Y, Zha J, Cogle C, Wang F, Xu B, Yang FC, Li W, So CWE, Qiu Y, Xu M, Huang S. HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-like Disease in Mice. Cancer Cell. 2019 PMID:31786140 | PMCID:PMC6917035
Goncalves J, Emmons MF, Faiao-Flores F, Aplin AE, Harbour JW, Licht JD, Wink MR, Smalley KSM. Decitabine limits escape from MEK inhibition in uveal melanoma. Pigment Cell Melanoma Res. 2019 PMID:31758842
Zhang X, Thummuri D, He Y, Liu X, Zhang P, Zhou D, Zheng G. Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-X(L). Chem Commun (Camb). 2019 PMID:31754664